Skip to main content

Advertisement

Log in

Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation: macrophage-targeted steroid therapy

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Hemophagocytic syndrome (HPS) induced by uncontrolled macrophage activation and subsequent graft failure is a frequent and prominent complication after allogeneic stem cell transplantation (allo-SCT), a cause of severe morbidity and death, and a therapeutic challenge. Liposome-incorporated dexamethasone, dexamethasone palmitate (DP), shows greater efficacy against macrophages as compared to dexamethasone sodium phosphate (DSP). Based on our findings that DP achieves significantly larger decrease than DSP on the viability of primary human macrophages compared in vitro, we tested the effects of DP in patients with HPS. A decrease in number of macrophages in the bone marrow and prevention of engraftment failure were observed in all patients without any severe complications. In conclusion, these data provide a rationale for testing DP as a first-line treatment for patients with HPS after allo-SCT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Takagi S, Masuoka K, Uchida N, et al. High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adults. Br J Haematol. 2009;147:543–53.

    Article  PubMed  Google Scholar 

  2. Sindrilaru A, Peters T, Wieschalka S, et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest. 2011;121:985–97.

    Article  PubMed  CAS  Google Scholar 

  3. Imahashi N, Inamoto Y, Ito M, et al. Clinical significance of hemophagocytosis in BM clot sections during the peri-engraftment period following allogeneic hematopoietic SCT. Bone Marrow Transplant. 2011 (in press).

  4. Koyama M, Sawada A, Yasui M, et al. Encouraging results of low-dose etoposide in the treatment of early-onset hemophagocytic syndrome following allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2007;86:466–7.

    Article  PubMed  Google Scholar 

  5. Fukunaga A, Nakamura F, Yoshinaga N, et al. Successful treatment with combined chemotherapy of two adult cases of hemophagocytic lymphohistiocytosis in recipients of umbilical cord blood cell transplantation. Int J Hematol. 2011;93:551–4.

    Article  PubMed  Google Scholar 

  6. Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med. 1976;84:304–15.

    PubMed  CAS  Google Scholar 

  7. Fukuno K, Tsurumi H, Yamada T, et al. Graft failure due to hemophagocytic syndrome after autologous peripheral blood stem cell transplantation. Int J Hematol. 2001;73:262–5.

    Article  PubMed  CAS  Google Scholar 

  8. Muller M, Renkawitz R. The glucocorticoid receptor. Biochim Biophys Acta. 1088;1991:171–82.

    Google Scholar 

  9. Pak CC, Fidler IJ. Liposomal delivery of biological response modifiers to macrophages. Biotherapy. 1991;3:55–64.

    Article  PubMed  CAS  Google Scholar 

  10. Martinez FO, Gordon S, Locati M, et al. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol. 2006;177:7303–11.

    PubMed  CAS  Google Scholar 

  11. Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25:677–86.

    Article  PubMed  CAS  Google Scholar 

  12. Sayer HG, Longton G, Bowden R, et al. Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention. Blood. 1994;84:1328–32.

    PubMed  CAS  Google Scholar 

  13. Inamoto Y, Ito M, Suzuki R, et al. Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy. Bone Marrow Transplant. 2009;44:43–9.

    Article  PubMed  CAS  Google Scholar 

  14. Camps IR. Risk factors for invasive fungal infections in haematopoietic stem cell transplantation. Int J Antimicrob Agents. 2008;32(Suppl 2):S119–23.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported in part by a grant from the Japan Society for the Promotion of Science to S.N., and in part by a Japanese Grant-in-Aid for Scientific Research [(C) 20591118] to T. Nakayama.

Conflict of interest

The authors declare conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Satoshi Nishiwaki or Takayuki Nakayama.

About this article

Cite this article

Nishiwaki, S., Nakayama, T., Murata, M. et al. Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation: macrophage-targeted steroid therapy. Int J Hematol 95, 428–433 (2012). https://doi.org/10.1007/s12185-012-1023-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-012-1023-z

Keywords

Navigation